Alice L Yu

Trials

Studies that name Alice L Yu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:36 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT00026312 · Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

  National Cancer Institute (NCI) · completed · Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma · principal investigator
• Ph2
  NCT00004658 · Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity

  National Center for Research Resources (NCRR) · completed · 5'-Nucleotidase Syndrome · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-11 16:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Predicting toxicity and success of anti-GD2 immunotherapy of neuroblastoma
  R01CA164132 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2012 to 2014 · $311,976 awarded in 2014
  Same name and institution; not confirmed by an ID
• IMMUNE MONITOR FOR COG TRIAL OF ANTI-GD2 IN NEUROBLASTOMA
  R01FD002319 · FDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2005 to 2009 · $332,155 awarded in 2009
  Same name and institution; not confirmed by an ID
• CLINICAL TRIAL OF ANTIID VACCINE FOR NEUROBLASTOMA
  R21CA078806 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 1998 to 1999 · $151,500 awarded in 1999
  Same name and institution; not confirmed by an ID
• PYRIMIDINE AND RIBOSE THERAPY IN DISORDERS OF NUCLEOTIDE METABOLISM
  M01RR000827 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 1985 to 1999 · $14,615 awarded in 1999
  Same name and institution; not confirmed by an ID
• EXPLOITATION OF FREQUENT P16 DELETION IN T-ALL THERAPY
  R21CA070397 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 1996 to 1997 · $151,000 awarded in 1997
  Same name and institution; not confirmed by an ID
• CLINICAL UTILITY OF A NEUROBLASTOMA MONOCLONAL ANTIBODY
  R01CA040186 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 1985 to 1987 · $190,856 awarded in 1987
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• PEDIATRIC ONCOLOGY GROUP
  U10CA030969 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI GREGORY H REAMAN · fiscal years 1985 to 2002
  Named on NCT00026312
• Children's Oncology Group Chair's Grant
  U10CA098543 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI PETER C. ADAMSON · fiscal years 2003 to 2013
  Named on NCT00026312
• COG NCTN Network Group Operations Center
  U10CA180886 · NCI · COG RESEARCH FOUNDATION, LLC · PI Douglas S. Hawkins · fiscal years 2014 to 2026
  Named on NCT00026312